ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,554,000 | -19.4% | 107,808 | -41.2% | 0.07% | -15.9% |
| Q2 2021 | $23,012,000 | +13.3% | 183,374 | +22.5% | 0.08% | -2.4% |
| Q1 2021 | $20,306,000 | -18.6% | 149,740 | -23.2% | 0.08% | -27.0% |
| Q4 2020 | $24,935,000 | +94.9% | 194,897 | +71.4% | 0.12% | +57.5% |
| Q3 2020 | $12,794,000 | +70.5% | 113,692 | +44.4% | 0.07% | +43.1% |
| Q2 2020 | $7,503,000 | +353.6% | 78,756 | +327.9% | 0.05% | +264.3% |
| Q1 2020 | $1,654,000 | +48.2% | 18,404 | -12.6% | 0.01% | +75.0% |
| Q4 2019 | $1,116,000 | – | 21,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |